OCTOBER 2024LIFE SCIENCES REVIEW4CONTENTSCONTENTSTHE TIPPING POINT FOR SCALABLE MANUFACTURING PROCESSES TO PIVOT GENE THERAPIESDr. Linda Randall, AVP, Biologics Development, Manufacturing & Control, PharmaronA PROPOSAL FOR A NEW STRATEGY IN ONCOLOGY CLINICAL DEVELOPMENTStefano Ferrara, Director, Clinical Science, BeiGeneIN MY OPINION08LAST WORD30COVER STORY 12GENOMICSSOLUTIONS PROVIDERS IN UK 2024TOP 5Transforming Patient Care with Synthetic BiologySyngensysProfessor David James, Chief Scientific Officer
< Page 3 | Page 5 >